Data Supports Smoking Cessation as Part Active Lung Cancer Treatment

NACLC 22 Educational Session Explores the Rationale for Immune Checkpoint Inhibition

Researcher Reveals How Air Pollution May Cause Lung Cancer

KEYNOTE-604 Follow-Up Results Continue to Show Clinically Meaningful Improvement

Study Shows Shorter-Term Assessments Underestimate Pollution Exposure

POSEIDON Analysis Shows Sustained Benefit with Triplet Regimen Regardless of Mutational Status

Growing Body of Evidence Highlights Potential Applications for Liquid Biopsy in Clinical Practice

IASLC Leadership Shares Experiences, Offers Advice for Women in Thoracic Oncology

When Perfect is the Enemy of Good: Investigators Compare Rigorous Clinical Trial Data to Real-World Experience

In Brief for Oct. 26, 2022

HER2 Mutations Present Unique Challenges in NSCLC

In Brief for Nov. 9, 2022